Review on tricuspid regurgitation, explaining the characterization of this valvulopathy, the new five-grade severity classification, and medical, surgical, and percutaneous treatment options.
Expert commentary from Dr. Carlos E. Martín provides an update on the percutaneous treatment of the mitral valve using transcatheter prostheses, reviewing the main technical aspects and results in studies published to date.
Long-Term Outcomes in a Japanese Cohort of Dialysis Patients Undergoing Aortic Valve Replacement with Biological and Mechanical Prostheses
This retrospective study from the Cleveland Clinic group assesses short- and long-term outcomes of tricuspid valve surgery for severe tricuspid regurgitation (TR) based on surgical indication (class I vs. non-class I).
Mid-Term Results of the SURE-AVR International Registry: A Decade of Perceval Sutureless Bioprosthesis Implantation
Sub-analysis of the CardioLink-2 clinical trial, evaluating the effect of mitral repair (resect vs. respect) on left ventricular (LV) reverse remodeling.
This prospective, observational, single-center study compares the incidence of postoperative delirium and quality of life in patients treated for aortic valve disease via surgery versus transcatheter procedure.
Five-Year Results and Preliminary Seven-Year Data from the COMMENCE Study on Edwards® RESILIA® Bovine Pericardial Tissue in Aortic Position Bioprostheses
An analysis of the technique and outcomes of the largest published series on the surgical implantation of balloon-expandable valves (Sapien) in patients with severe mitral annular calcification (MAC).
A patient-level meta-analysis involving 38 studies and over 25,000 patients, assessing the impact on survival and readmission needs among patients with residual paravalvular leak classified as none, mild, or moderate-severe after TAVI.
If you wish to receive our monthly newsletter, containing all the news collected on our portal, please fill in your email address and click on the “Subscribe” button.